t.marchetti
TL2 · Antalya
Contributes reviews on supplier material. Based in Antalya.
Joined 18 August 2025 · last posted 8d
90Posts here
0Topics
0Solutions
1.2kLikes received
1kLikes given
19Badges
197Days visited
3.7kPosts read
Recent activity
Full stream-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #86 · Access › Insurance & coverage · 20 Jul 2026 · 30 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
What a certificate commits its issuer to Replied, post #44 · Analytics › COA interpretation · 17 Jul 2026 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #39 · Start Here › Welcome · 13 Jul 2026 · 10 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #82 · Practice › Storage & stability · 2 Jul 2026 · 26 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #16 · Compounds › Cagrilintide & amylin analogues · 29 Jun 2026 · 32 likes Comparing an amylin analogue to an incretin agonist on weight change alone misses that they were developed to be used together rather than instead of each other. I…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #65 · Compounds › Oral incretins · 29 Jun 2026 · 11 likes Post #61 put the caveat in the right place and I want to underline it. Trial adherence in an oral trial with strict administration requirements is genuinely worse than…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #8 · Evidence › Preprints · 25 Jun 2026 · 1 like Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Official shortage notices and what they authorise Replied, post #115 · Access › Shortages · 19 Jun 2026 · 8 likes Adding the measurement that post #113 says would settle it. Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #126 · Practice › Interactions · 15 Jun 2026 · 13 likes A methods point on Metformin co-administration rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference…
-
Private prescribing in the UK: what is actually involved Replied, post #36 · Regional › UK & Ireland · 11 Jun 2026 · 24 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Racemisation and why it is invisible to a mass measurement Replied, post #33 · Analytics › Impurities & related substances · 10 Jun 2026 · 7 likes Answering the question post #31 raises rather than the one it answers. Reporting thresholds matter: below a stated threshold, peaks are usually not reported at all. A…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #29 · Compounds › Secretagogues & GH axis · 9 Jun 2026 · 0 likes Post #28 is right about the mechanism and I think understates the practical bit. On analysis: these are short peptides and generally straightforward…